{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:55:55Z","timestamp":1793105755950,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jneuroim.2021.577787","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T18:34:46Z","timestamp":1639247686000},"page":"577787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets"],"prefix":"10.1016","volume":"362","author":[{"given":"Jie","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2021.577787_bb0005","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0015","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-gamma, and GM-CSF and diminished IL-10 production","volume":"196","author":"Cao","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3389\/fphar.2018.00801","article-title":"Polypharmacology of berberine based on multi-target binding motifs","volume":"9","author":"Chu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1405.042","article-title":"CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis","volume":"1132","author":"Conti-Fine","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/carcin\/bgy023","article-title":"Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells","volume":"39","author":"Corominas-Faja","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1756285615605700","article-title":"Future perspectives in target-specific immunotherapies of myasthenia gravis","volume":"8","author":"Dalakas","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41582-018-0110-z","article-title":"Immunotherapy in myasthenia gravis in the era of biologics","volume":"15","author":"Dalakas","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuro.2016.10.008","article-title":"Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer\u2019s-like dementia: involvement of acetylcholinesterase and cell death","volume":"57","author":"de Oliveira","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0050","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10495-019-01548-6","article-title":"Berberine mitigates IL-21\/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17\/Treg imbalance in rheumatoid arthritis","volume":"24","author":"Dinesh","year":"2019","journal-title":"Apoptosis"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106270","article-title":"Effect of berberine on spleen transcriptome and gut microbiota composition in experimental autoimmune uveitis","volume":"81","author":"Du","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0065","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0070","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0075","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neurobiolaging.2018.09.001","article-title":"Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals","volume":"73","author":"Han","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0090","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0095","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ene.13300","article-title":"Multiple antibody detection in \u2018seronegative\u2019 myasthenia gravis patients","volume":"24","author":"Hong","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0065-2776(03)81008-8","article-title":"Control of autoimmunity by naturally arising regulatory CD4+ T cells","volume":"81","author":"Hori","year":"2003","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0105","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/382174a0","article-title":"Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice","volume":"382","author":"Kaplan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22060925","article-title":"Phytochemical quantification and the in vitro acetylcholinesterase inhibitory activity of phellodendron chinense and its components","volume":"22","author":"Kim","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1196\/annals.1405.019","article-title":"Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis","volume":"1132","author":"Le Panse","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0125","doi-asserted-by":"crossref","first-page":"1628592","DOI":"10.1080\/20013078.2019.1628592","article-title":"Acetylcholinesterase is not a generic marker of extracellular vesicles","volume":"8","author":"Liao","year":"2019","journal-title":"J. Extracell. Vesicle"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0130","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1021\/acs.jmedchem.0c00192","article-title":"Selective Janus Kinase 2 (JAK2) pseudokinase ligands with a diaminotriazole core","volume":"63","author":"Liosi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biopha.2016.02.015","article-title":"Protective mechanisms of berberine against experimental autoimmune myocarditis in a rat model","volume":"79","author":"Liu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108492","article-title":"Circulating Th1\/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients","volume":"218","author":"Ma","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0145","first-page":"526","article-title":"Therapeutic potential of artesunate in experimental autoimmune myasthenia gravis by upregulated T regulatory cells and regulation of Th1\/Th2 cytokines","volume":"73","author":"Meng","year":"2018","journal-title":"Pharmazie"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0150","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","article-title":"Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis","volume":"128","author":"Mu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2021.577787_bb0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fphar.2018.00557","article-title":"Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders","volume":"9","author":"Neag","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrd.2017.267","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"17","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0170","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.jsxm.2019.08.014","article-title":"Role of JAK2 in the pathogenesis of diabetic erectile dysfunction and an intervention with berberine","volume":"16","author":"Song","year":"2019","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2019.05.006","article-title":"Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis","volume":"203","author":"Song","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","article-title":"Functional defect in regulatory T cells in myasthenia gravis","volume":"1274","author":"Thiruppathi","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2017.05.040","article-title":"Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3","volume":"656","author":"Wang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2021.577787_bb0195","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/aps.2015.136","article-title":"Berberine protects rat heart from ischemia\/reperfusion injury via activating JAK2\/STAT3 signaling and attenuating endoplasmic reticulum stress","volume":"37","author":"Zhao","year":"2016","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821003143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821003143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:40:42Z","timestamp":1759048842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572821003143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":39,"alternative-id":["S0165572821003143"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577787","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577787"}}